Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

A phase I trial with a hybrid cell vaccine in patients with metastatic melanoma.

A phase I trial with a hybrid cell vaccine in patients with metastatic melanoma. Adv Exp Med Biol. 1998; 451:519-25.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.